Abstract
Objective: DACH1 is a rarely studied tumor suppressor gene that is frequently mutated in melanoma and bladder and prostate cancer; however, scant data exist in the endometrial cancer population likely because of its low mutation frequency in cBioPortal. The objective of this work was to determine the frequency of somatic mutations, particularly in DACH1, in patients with endometrial cancer at the University of Kentucky Hospital and to compare mutation frequency with that of other publicly available data resources.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
